These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1507 related items for PubMed ID: 24894085
1. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo. Liu P, Li F, Qiu M, He L. Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085 [Abstract] [Full Text] [Related]
2. 1,25(OH)2D3 provides protection against diabetic kidney disease by downregulating the TLR4-MyD88-NF-κB pathway. Liu P, Li F, Xu X, Li S, Dong X, Chen L, Bai B, Wang Y, Qiu M, Dong Y. Exp Mol Pathol; 2020 Jun; 114():104434. PubMed ID: 32240615 [Abstract] [Full Text] [Related]
3. Liraglutide ameliorates inflammation and fibrosis by downregulating the TLR4/MyD88/NF-κB pathway in diabetic kidney disease. Huang L, Lin T, Shi M, Wu P. Am J Physiol Regul Integr Comp Physiol; 2024 Oct 01; 327(4):R410-R422. PubMed ID: 39133777 [Abstract] [Full Text] [Related]
4. Fluvastatin inhibits high glucose-induced nuclear factor kappa B activation in renal tubular epithelial cells. Gao P, Wu X, Shui H, Jia R. J Nephrol; 2013 Oct 01; 26(2):289-96. PubMed ID: 22641573 [Abstract] [Full Text] [Related]
5. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling. Han W, Ma Q, Liu Y, Wu W, Tu Y, Huang L, Long Y, Wang W, Yee H, Wan Z, Tang R, Tang H, Wan Y. Phytomedicine; 2019 Apr 01; 57():203-214. PubMed ID: 30785016 [Abstract] [Full Text] [Related]
6. BMP-7/Smads-induced inhibitor of differentiation 2 (Id2) upregulation and Id2/Twist interaction was involved in attenuating diabetic renal tubulointerstitial fibrosis. Xiao Y, Jiang X, Peng C, Zhang Y, Xiao Y, Liang D, Shi M, Wang Y, Zhang F, Guo B. Int J Biochem Cell Biol; 2019 Nov 01; 116():105613. PubMed ID: 31539631 [Abstract] [Full Text] [Related]
7. Atorvastatin reduces contrast media-induced pyroptosis of renal tubular epithelial cells by inhibiting the TLR4/MyD88/NF-κB signaling pathway. Yue RZ, Li YJ, Su BH, Li CJ, Zeng R. BMC Nephrol; 2023 Feb 02; 24(1):25. PubMed ID: 36732683 [Abstract] [Full Text] [Related]
8. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy. Jheng HF, Tsai PJ, Chuang YL, Shen YT, Tai TA, Chen WC, Chou CK, Ho LC, Tang MJ, Lai KT, Sung JM, Tsai YS. Dis Model Mech; 2015 Oct 01; 8(10):1311-21. PubMed ID: 26398934 [Abstract] [Full Text] [Related]
9. Pharmacological inhibition of MyD88 suppresses inflammation in tubular epithelial cells and prevents diabetic nephropathy in experimental mice. Zhang QY, Xu SJ, Qian JC, Yang LB, Chen PQ, Wang Y, Hu X, Zhang YL, Luo W, Liang G. Acta Pharmacol Sin; 2022 Feb 01; 43(2):354-366. PubMed ID: 34552217 [Abstract] [Full Text] [Related]
10. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy. Lu Q, Ji XJ, Zhou YX, Yao XQ, Liu YQ, Zhang F, Yin XX. Pharmacol Res; 2015 Sep 01; 99():237-47. PubMed ID: 26151815 [Abstract] [Full Text] [Related]
11. [Effect of spironolactone on the expression of Toll-like receptor 4 in renal tubular epithelia cells exposed to high glucose]. Liu KH, Zhou QL, Ao X, Tang TF, Hong XM, Bao RL. Zhongguo Dang Dai Er Ke Za Zhi; 2010 Apr 01; 12(4):280-3. PubMed ID: 20416221 [Abstract] [Full Text] [Related]
12. [Effects of fosinopril and losartan on the expression of Toll- like receptor 4 in renal tubular epithelia cells]. Tang TF, Zhou QL, Zhu LL, Tang R, Ao X. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Oct 01; 33(10):958-65. PubMed ID: 19001741 [Abstract] [Full Text] [Related]
13. [Alveolar macrophage TLR4/MyD88 signaling pathway contributes to ventilator-induced lung injury in rats]. Huang C, Pan L, Lin F, Qian W, Li W. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb 01; 31(2):182-5, 189. PubMed ID: 25652858 [Abstract] [Full Text] [Related]
14. Colchicine attenuates inflammatory cell infiltration and extracellular matrix accumulation in diabetic nephropathy. Li JJ, Lee SH, Kim DK, Jin R, Jung DS, Kwak SJ, Kim SH, Han SH, Lee JE, Moon SJ, Ryu DR, Yoo TH, Han DS, Kang SW. Am J Physiol Renal Physiol; 2009 Jul 01; 297(1):F200-9. PubMed ID: 19369290 [Abstract] [Full Text] [Related]
15. Effects of shuangtengbitong tincture on collagen‑induced arthritis in rats. Xu W, Li H, Chu K, Zhang Y, Zheng H, Huang M, Zhang X, Chen L. Mol Med Rep; 2013 Nov 01; 8(5):1479-85. PubMed ID: 24065119 [Abstract] [Full Text] [Related]
16. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. Lin M, Yiu WH, Wu HJ, Chan LY, Leung JC, Au WS, Chan KW, Lai KN, Tang SC. J Am Soc Nephrol; 2012 Jan 01; 23(1):86-102. PubMed ID: 22021706 [Abstract] [Full Text] [Related]
17. Human umbilical cord mesenchymal stem cell conditioned medium attenuates renal fibrosis by reducing inflammation and epithelial-to-mesenchymal transition via the TLR4/NF-κB signaling pathway in vivo and in vitro. Liu B, Ding F, Hu D, Zhou Y, Long C, Shen L, Zhang Y, Zhang D, Wei G. Stem Cell Res Ther; 2018 Jan 12; 9(1):7. PubMed ID: 29329595 [Abstract] [Full Text] [Related]
18. Effect of the TLR2/MyD88/NF-κB axis on corneal allograft rejection after penetrating keratoplasty. Wu W, Yu S, Feng S, Yang J, Lu X. J Recept Signal Transduct Res; 2016 Jan 12; 36(1):45-52. PubMed ID: 25800037 [Abstract] [Full Text] [Related]
19. NQO1 alleviates renal fibrosis by inhibiting the TLR4/NF-κB and TGF-β/Smad signaling pathways in diabetic nephropathy. Qiu D, Song S, Chen N, Bian Y, Yuan C, Zhang W, Duan H, Shi Y. Cell Signal; 2023 Aug 12; 108():110712. PubMed ID: 37196773 [Abstract] [Full Text] [Related]
20. Bergenin ameliorates diabetic nephropathy in C57BL/6 J mice by TLR4/MyD88/NF-κB signalling pathway regulation. Quan Y, Su P, Shangguan C, Hao H, Yue L, Chen C. Toxicol Appl Pharmacol; 2023 Sep 15; 475():116633. PubMed ID: 37482253 [Abstract] [Full Text] [Related] Page: [Next] [New Search]